Skip to content
EC
Private Equity

Updated:

Enzyme Capital

Enzyme is the global infrastructure for tokenized finance. It empowers businesses and institutions with a comprehensive suite of products to create and...

Overview

Enzyme is the global infrastructure for tokenized finance. It empowers businesses and institutions with a comprehensive suite of products to create and manage next-generation financial products and strategies. Originally designed exclusively for asset managers, it evolved after eight years into infrastructure empowering businesses and institutions to scale through tokenization.

General information

Firm type

Private Equity

Year founded

2017

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Principals

Mona El Isa

Founder

Sector focus

Tokenized finance and decentralized finance

Frequently asked questions

Does Enzyme Capital co-invest alongside other venture firms?

Enzyme Capital's approach to co-investing is not publicly documented. As an early-stage firm operating in Beijing's venture ecosystem, participation in syndicated seed rounds alongside other specialist funds is common practice, but no specific co-investment partners or deal syndicates have been confirmed through public record or the firm's own disclosures.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Private Equity profiles